GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Times Interest Earned (2009 - 2026)

Updated

GT Biopharma's (GTBP) Times Interest Earned stood at -70.50 in Q2 2026.

Analysis

GT Biopharma (GTBP) Times Interest Earned (2009 - 2026) Analysis & Trends

On a TTM basis, GT Biopharma's Times Interest Earned came in at -16337.00 as of Jun 30, 2026; for FY2025, it was -97.81.

  • Across earlier years, Times Interest Earned came in at -63.74 in FY2023, -2657.13 in FY2022 and -80.10 in FY2021.
  • The Q2 2026 figure is the lowest quarterly Times Interest Earned since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 28.50
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.20
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 5.68
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 12.87
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 GT Biopharma 6.65 Mn -16.58 Mn - -70.50
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -70.50
Mar 31, 2026 -45.21
Jun 30, 2023 -3,621.00
Mar 31, 2023 -17.29
Dec 31, 2021 -826.27
Mar 31, 2021 -41.67
Dec 31, 2020 1.23
Sep 30, 2020 -2.09
Jun 30, 2020 -0.33
Mar 31, 2020 1.68
Dec 31, 2019 8.63
Sep 30, 2019 -15.81
Jun 30, 2019 -4.76
Mar 31, 2019 -8.93
Dec 31, 2018 -2.71
Sep 30, 2018 -208.96
Jun 30, 2018 -1.31
Mar 31, 2018 -2.44
Dec 31, 2017 -43.64
Sep 30, 2017 -33.66
API Access

GT Biopharma Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=GTBP&period=max&api_key=YOUR_API_KEY